Related Experiment Video
Updated: Aug 5, 2025
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment
Joshua B Parsons1,2, Annette C Westgeest1,3, Brian P Conlon2
1Department of Medicine, Division of Infectious Disease, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is a devastating pathogen responsible for a variety of life-threatening infections. A distinctive characteristic of this pathogen is its ability to persist in the bloodstream for several days despite seemingly appropriate antibiotics. Persistent MRSA bacteremia is common and is associated with poor clinical outcomes. The etiology of persistent MRSA bacteremia is a result of the complex interplay between the host, the pathogen, and the antibiotic used to treat the infection. In this review, we explore the factors related to each component of the host-pathogen interaction and discuss the clinical relevance of each element. Next, we discuss the treatment options and diagnostic approaches for the management of persistent MRSA bacteremia.
Insights
Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia poses a significant clinical challenge. This review examines host, pathogen, and antibiotic factors contributing to persistent MRSA bloodstream infections and their management.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) causes severe infections.
- Persistent MRSA bacteremia, despite antibiotics, is linked to poor outcomes.
- Understanding the host-pathogen-antibiotic interaction is crucial.
Purpose of the Study:
- To review factors contributing to persistent MRSA bacteremia.
- To explore the clinical relevance of host-pathogen interactions.
- To discuss current treatment and diagnostic strategies.
Main Methods:
- Literature review of host, pathogen, and antibiotic factors.
- Analysis of clinical relevance of identified elements.
- Synthesis of treatment and diagnostic approaches.
Main Results:
- Persistent MRSA bacteremia results from complex host-pathogen-antibiotic interplay.
- Specific host defenses, pathogen virulence factors, and antibiotic properties influence persistence.
- Effective management requires a multifaceted approach.
Conclusions:
- Persistent MRSA bacteremia necessitates a comprehensive understanding of contributing factors.
- Tailored treatment and diagnostic strategies are essential for improved patient outcomes.
- Further research into host-pathogen dynamics can optimize therapeutic interventions.
Related Concept Videos
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:25Urinary Tract Infection II: Pathophysiology
01:30Development of Antibiotic Resistance
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
01:25Endocarditis I: Introduction
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...